Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced the pricing of an underwritten registered public offering of 1,506,025 shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE